AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Cadpride M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Caddes Life Sciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Cadpride M 1mg/500mg Tablet SR

Diabexe Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Diabexe Duo should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose levels and potential complications like nephropathy, retinopathy, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to identify symptoms—sweating, dizziness, headache, tremors—and manage them appropriately. Regular meals and carrying a readily available fast-acting glucose source (e.g., sugary snacks, juice) are preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional side effects may include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is a possibility. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Cadpride M 1mg/500mg Tablet SR

No information provided. Therefore, no rephrased text can be generated.

Uses of Cadpride M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Cadpride M 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Take Cadpride M 1mg/500mg Sustained-Release tablets with food.

Common Side effects of Cadpride M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Cadpride M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Cadpride M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

How Cadpride M 1mg/500mg Tablet SR works:

Cadpride M 1mg/500mg Extended-Release Tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Cadpride M 1mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Cadpride M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

Extended-release Cadpride M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Cadpride M 1mg/500mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Cadpride M 1mg/500mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended throughout the treatment period.

LiverLiverCAUTION

Exercise caution when prescribing Cadpride M 1mg/500mg SR tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. A reduced initial dose of Cadpride M 1mg/500mg SR tablets is typically recommended for patients exhibiting mild to moderate liver dysfunction; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Cadpride M 1mg/500mg Tablet SR :

Should you forget to take a Cadpride M 1mg/500mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Cadpride M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Cadpride M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Cadpride M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Cadpride M 1mg/500mg Tablet SR and seek immediate medical attention.
Cadpride M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Cadpride M 1mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Cadpride M 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Cadpride M 1mg/500mg Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Cadpride M 1mg/500mg Tablet SR with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Cadpride M 1mg/500mg Tabl...
42
MRP 49
14% off